Daniel Schofield's blog
Defining a Valid Prescriber: Data Sources
Recently, I was asked to join the National Council for Prescription Drug Programs’ (NCPDP) task group to help define “what is a valid prescriber?” As the pharmacy solution lead at Health Market Science, I bring a wealth of knowledge about the necessary data sources, already found in the HMS Provider MasterFile, to define a valid prescriber.
Key 2012 Call Letter Effective Date Confirmed with Center for Medicaid and Medicare Services (CMS)
At last week’s webinar, The New “Must Haves” for Part D Payers: Valid Prescriber Identifiers and DEA Schedule Registration, attendees wanted to know effective dates for the new DEA Schedule Registration.
Timing is everything. Government Compliance Webinar Addresses CMS 2012 Call Letter and NEW DEA Schedule Regs.
This Thursday, October 13, Health Market Science is conducting The New “Must Haves” for Part D Payers: Valid Prescriber Identifiers and DEA Schedule Registration, the second in the Government Compliance Webinar Series. This session has the very latest on the new DEA registration regulations, formerly known as Scope of Practice. The webinar starts at 1:00 p.m. EDT. Register here.
Navigating the 2012 CMS Call Letter: Scope of Practice Part II
In my previous blog, I ruminated on what it might mean to implement solutions to meet the requirements in CMS’ 2012 Call Letter.
Sphere of Influence: Navigating "Scope of Practice" for Prescribers
CMS’ draft call letter for 2012 raises some interesting questions regarding “Scope of Practice”. Specifically, CMS will require Part D sponsors to validate DEA numbers for prescribed Schedule II controlled substances, and further ensure that the drug is within the prescribers “Scope of Practice”. A portion of CMS’ document says:
